Podcast Episodes
Back to SearchRNA-Based Therapeutics With Nutcracker Therapeutics' Dr. Geoff Nosrati
We love to hear from our listeners. Send us a message.
Nutcracker Therapeutics is a preclinical biopharma company developing multimodal RNA-based th…
3 years, 5 months ago
Tick-Derived Therapeutic Molecules With Akari Therapeutics' Rachelle Jacques
We love to hear from our listeners. Send us a message.
Ticks are a scourge. They're vectors of multiple serious an debilitating diseases, and evoluti…
3 years, 5 months ago
Product vs. Platform With Surface's Vito Palombella, Ph.D. and Robert Ross, M.D.
We love to hear from our listeners. Send us a message.
Earlier this month, Surface Oncology shared that it will open a second stage of its monotherap…
3 years, 5 months ago
Leveraging Lymph Nodes With Elicio's Dr. Peter DeMuth
We love to hear from our listeners. Send us a message.
MIT-born startup Elicio Therapeutics' novel Amphiphile Technology Platform is designed to dire…
3 years, 5 months ago
Engineering Proteins For Food Allergies With Ukko's Dr. Anat Binur
We love to hear from our listeners. Send us a message.
Anat Binur, Ph.D. is CEO and Co-Founder at Ukko, where she's leading an effort to create new a…
3 years, 5 months ago
Anatomy Of A VC Deal With 4BIO's Dima Kuzmin & Ray Therapeutics' Paul Bresge
We love to hear from our listeners. Send us a message.
In a particularly candid conversation, 4BIO Managing Partner Dmitry ‘Dima’ Kuzmin and Ray Ther…
3 years, 6 months ago
Oncology Discovery Advances With AbbVie's Steve Davidsen, Ph.D.
We love to hear from our listeners. Send us a message.
AbbVie VP of Oncology Discovery Research Steve Davidsen, Ph.D. is a living, breathing timeli…
3 years, 6 months ago
IND For TIL Therapy With Obsidian Therapeutics' Paul Wotton, Ph.D.
We love to hear from our listeners. Send us a message.
On this episode of The Business of Biotech, Obsidian Therapeutics CEO Paul Wotton, Ph.D. takes…
3 years, 6 months ago
Regenerative Wound Care With BioStem Technologies' Jason Matuszewski & Andrew VanVurst
We love to hear from our listeners. Send us a message.
Here's the story of BioStem, it's young founders, and how they reached commercial status in sh…
3 years, 6 months ago
Epigenomic Programming With Omega Therapeutics' Mahesh Karande
We love to hear from our listeners. Send us a message.
Using computational biology to hasten the effort, Omega Therapeutics' plan is to "coopt natur…
3 years, 7 months ago